INTERNATIONAL BIO SERVICE LTD

INTERNATIONAL BIO SERVICE LTD is a trading company.

Company Introduction:

INTERNATIONAL BIO SERVICE LTD is a prominent distributor and service provider based in Thailand, specializing in the marketing and distribution of high-quality medical devices, in vitro diagnostic products, and life science research instruments and reagents. The company acts as a trusted local partner for numerous international manufacturers, bringing cutting-edge technologies and solutions to the Thai market.

With a strong focus on customer satisfaction, INTERNATIONAL BIO SERVICE LTD provides comprehensive sales, marketing, application support, and after-sales technical services. Their clientele includes hospitals, clinical laboratories, academic institutions, research centers, and industrial sectors throughout Thailand. The company's mission is to enhance healthcare and scientific research capabilities in the region by offering reliable products and expert support.

International Bio Service Co., Ltd. (IBS) in Thailand is primarily a Contract Research Organization (CRO) and does not directly manufacture or sell typical consumer or general pharmaceutical products.

Instead, their services and expertise center around the research and development phases for generic pharmaceuticals, specifically:

Bioequivalence (BE) and Bioavailability (BA) Studies:

The core service is conducting comparative studies (clinical and bioanalytical) to determine if a generic drug is equivalent to an original/reference drug.

Bioanalytical Services:

Developing and validating in-house methods for analyzing drug levels in plasma/biological samples. They have experience with a wide range of therapeutic molecules, including, but not limited to, those in the Cardiovascular area (e.g., Amlodipine/Valsartan, Atorvastatin, Apixaban, Bilastine, Bisoprolol, Bosentan, Candesartan, etc.).

Clinical Services:

Conducting the clinical phase of BE/BA studies under Good Clinical Practice (GCP) guidelines.

Laboratory Services:

Providing the laboratory phase of the studies under Good Laboratory Practice (GLP) principles.

In essence, their "products" are specialized research and analysis services that support the registration and approval of generic pharmaceuticals, rather than sellable retail or wholesale products.